Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Thill

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Breast Care (Basel, Switzerland)|July 1, 2026
Pre-Pectoral Breast Reconstruction after Mastectomy: Current Evidence, Knowledge Gaps, and Rationale for the I-PREPARE EUBREAST-11R TrialRosa Di Micco, Lorenzo Scardina, Edoardo Botteri, et al.
Geburtshilfe Und Frauenheilkunde|May 19, 2025
Update Breast Cancer 2024 Part 3 - Patients with Advanced Stage Breast CancerDiana Lüftner, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|November 2, 2023
Update Breast Cancer 2023 Part 1 - Early Stage Breast CancerAndreas D Hartkopf, Tanja N Fehm, Manfred Welslau, et al.
Geburtshilfe Und Frauenheilkunde|November 2, 2023
Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast CancerMichael P Lux, Andreas D Hartkopf, Tanja N Fehm, et al.
Geburtshilfe Und Frauenheilkunde|September 14, 2023
Update Breast Cancer 2023 Part 3 - Expert Opinions of Early Stage Breast Cancer TherapiesHans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, et al.
Cancers|April 3, 2021
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA StudyMaggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de Boniface, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2025
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trialRosa Di Micco, Steffi Hartmann, Maggie Banys-Paluchowski, et al.
Geburtshilfe Und Frauenheilkunde|May 19, 2025
Update Breast Cancer 2024 Part 2 - Patients with Early Stage Breast CancerWolfgang Janni, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Breast (Edinburgh, Scotland)|March 27, 2025
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence riskVolkmar Müller, Manuel Hörner, Marc Thill, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2024
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current ProgramsAndreas Schneeweiss, Sara Y Brucker, Hanna Huebner, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Breast Care (Basel, Switzerland)|July 1, 2026
Pre-Pectoral Breast Reconstruction after Mastectomy: Current Evidence, Knowledge Gaps, and Rationale for the I-PREPARE EUBREAST-11R TrialRosa Di Micco, Lorenzo Scardina, Edoardo Botteri, et al.
Geburtshilfe Und Frauenheilkunde|May 19, 2025
Update Breast Cancer 2024 Part 3 - Patients with Advanced Stage Breast CancerDiana Lüftner, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|November 2, 2023
Update Breast Cancer 2023 Part 1 - Early Stage Breast CancerAndreas D Hartkopf, Tanja N Fehm, Manfred Welslau, et al.
Geburtshilfe Und Frauenheilkunde|November 2, 2023
Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast CancerMichael P Lux, Andreas D Hartkopf, Tanja N Fehm, et al.
Geburtshilfe Und Frauenheilkunde|September 14, 2023
Update Breast Cancer 2023 Part 3 - Expert Opinions of Early Stage Breast Cancer TherapiesHans-Christian Kolberg, Andreas D Hartkopf, Tanja N Fehm, et al.
Cancers|April 3, 2021
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA StudyMaggie Banys-Paluchowski, Maria Luisa Gasparri, Jana de Boniface, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2025
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trialRosa Di Micco, Steffi Hartmann, Maggie Banys-Paluchowski, et al.
Geburtshilfe Und Frauenheilkunde|May 19, 2025
Update Breast Cancer 2024 Part 2 - Patients with Early Stage Breast CancerWolfgang Janni, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Breast (Edinburgh, Scotland)|March 27, 2025
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence riskVolkmar Müller, Manuel Hörner, Marc Thill, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2024
CDK4/6 Inhibition - Therapy Sequences and the Quest to Find the Best Biomarkers - an Overview of Current ProgramsAndreas Schneeweiss, Sara Y Brucker, Hanna Huebner, et al.
Pageof 17